| Financial Year |
March 31 2023 |
| Monetary Funds |
253,867,261.69 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
461,885,825.70 |
| Advances to Suppliers |
216,179,732.40 |
| Other Receivables |
11,631,683.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
303,334,956.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,949,613.12 |
| Total Current Assets |
1,329,769,264.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,630,956.60 |
| Investment Properties |
2,004,901.24 |
| Fixed Assetes |
1,066,487,733.66 |
| Under-construction Projects |
97,941,633.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
87,112,422.49 |
| R&D expenses |
38,337,240.41 |
| Goodwill |
21,071,947.29 |
| Long-Term Deferred and Prepaid Expenses |
3,023,189.64 |
| Deferred Income Tax Assets |
20,985,596.29 |
| Other Non-Current Assets |
37,579,699.84 |
| Sub-Total of Non-Current Assets |
1,377,175,321.07 |
| Total Assets |
2,706,944,585.94 |
| Short-Term Loans |
535,784,623.28 |
| Trading Financial liabilities |
-- |
| Notes Payable |
103,968,791.35 |
| Accounts Payable |
146,793,121.50 |
| Accounts Received In Advance |
125,025,829.00 |
| Employee Compensation Payable |
9,197,101.93 |
| Taxes Payable |
19,797,752.52 |
| Interest Payable |
-- |
| Dividend Payable |
116,400.00 |
| Other payables |
159,980,939.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
48,807,986.30 |
| Other Current Liabilities |
14,105,216.62 |
| Sub-Total of Current Liabilities |
1,200,125,273.87 |
| Long-term Loans |
49,650,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
367,500.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,870,079.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
57,165,226.87 |
| Total Liabilities |
1,257,290,500.74 |
| Paid-In Capital(Or Share Stock) |
287,145,674.00 |
| Capital Surplus |
269,802,178.08 |
| Surplus Reserve |
83,700,440.89 |
| LESS:Treasury Stock |
6,512,652.42 |
| Undistributed Profits |
664,469,311.56 |
| Minority Stockholder's Interest |
151,049,133.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,298,604,952.11 |
| Owner's Equity（Stockholder's Equity） |
1,449,654,085.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,706,944,585.94 |
